Company: IPHYF
Filing Date: 2025-04-30
Form Type: 20-F
Source: 0001598599-25-000042
Chunk: 224

Company: Innate Pharma SA
Filing Date: 2025-04-30
Form: 20-F
Item: Item 6
Chunk 224
---
 receive ordinary shares under certain conditions. Upon grant by the Executive Board of the Company, the AGA are subject to an acquisition, or vesting, period of at least one year. At the end of this period, the free shares vest and the beneficiary becomes a full shareholder. However, if the vesting period is less than a certain period set by law (currently two years), it must be followed by a holding period, so that the sum of the vesting period and the holding period is equal to a minimum total period also set by law (currently two years). Vesting can be conditional or not. The vesting of all or the Company's AGA is subject to a presence condition at the end of the vesting period. Some of the Company's AGA are also subject to performance conditions. Over the years, the Company has established several AGA plans, for its employees or for management only, sometimes as a “welcome package” (with no performance conditions). The Company's free share plans include provisions that allow for the adjustment of the number of ordinary shares to which a beneficiary is entitled at the end of the vesting period to compensate for certain modifications of its share capital, such as rights issues, stock splits, mergers and other events affecting all existing shareholders, during the vesting period. Certain of the Company's plans also provide for an accelerated vesting in case of a tender offer on the Company during the vesting period.

The following table shows the AGAs outstanding as of December 31, 2024:

  Plan title (1)                                                    AGA Perf Employees 2022      AGA Perf Management 2022      AGA Perf Employees 2023      AGA Perf Management 2023      AGA Perf Employees 2024      AGA Perf Management 2024-1      AGA Perf Management 2024-2  
  Shareholder general meeting date                                  May 20, 2022                 May 20, 2022                  May 12, 2023                 May 12, 2023                  May 23, 2024                 May 23, 2024                    May 23, 2024                
  Date of grant                                                     December 12, 2022            December 12, 2022             December 21, 2023            December 21, 2023             November 13, 2024            August 1, 2024                  November 13, 2024           
  Vesting Period                                                    3 years                      3